BG63488B1 - Таблети с високо съдържание на фамцикловир - Google Patents

Таблети с високо съдържание на фамцикловир Download PDF

Info

Publication number
BG63488B1
BG63488B1 BG102638A BG10263898A BG63488B1 BG 63488 B1 BG63488 B1 BG 63488B1 BG 102638 A BG102638 A BG 102638A BG 10263898 A BG10263898 A BG 10263898A BG 63488 B1 BG63488 B1 BG 63488B1
Authority
BG
Bulgaria
Prior art keywords
tablet
famciclovir
tablets
content
phamcyclovir
Prior art date
Application number
BG102638A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102638A (bg
Inventor
Michael GREENWAY
Jennifer SLATER
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG102638A publication Critical patent/BG102638A/xx
Publication of BG63488B1 publication Critical patent/BG63488B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BG102638A 1996-01-16 1998-07-15 Таблети с високо съдържание на фамцикловир BG63488B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals
PCT/EP1997/000195 WO1997025990A1 (en) 1996-01-16 1997-01-13 High-content famciclovir tablets

Publications (2)

Publication Number Publication Date
BG102638A BG102638A (bg) 1999-07-30
BG63488B1 true BG63488B1 (bg) 2002-03-29

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102638A BG63488B1 (bg) 1996-01-16 1998-07-15 Таблети с високо съдържание на фамцикловир

Country Status (37)

Country Link
US (1) US6765007B1 (de)
EP (1) EP0874632B1 (de)
JP (2) JP4711360B2 (de)
KR (1) KR100338829B1 (de)
CN (1) CN1132582C (de)
AP (2) AP747A (de)
AR (1) AR005456A1 (de)
AT (1) ATE220910T1 (de)
AU (1) AU713090B2 (de)
BG (1) BG63488B1 (de)
BR (1) BR9706982A (de)
CY (1) CY2390B1 (de)
CZ (1) CZ287205B6 (de)
DE (1) DE69714215T2 (de)
DK (1) DK0874632T3 (de)
DZ (1) DZ2159A1 (de)
EA (1) EA001946B1 (de)
EG (1) EG23684A (de)
ES (1) ES2180922T3 (de)
GB (1) GB9600847D0 (de)
HU (1) HU225472B1 (de)
IL (1) IL124913A0 (de)
MX (1) MX9805713A (de)
MY (1) MY127527A (de)
NO (1) NO315689B1 (de)
NZ (1) NZ326769A (de)
OA (1) OA10812A (de)
PE (1) PE35498A1 (de)
PL (1) PL187291B1 (de)
PT (1) PT874632E (de)
SK (1) SK282132B6 (de)
TR (1) TR199800954T2 (de)
TW (1) TW434016B (de)
UA (1) UA63897C2 (de)
UY (2) UY24437A1 (de)
WO (1) WO1997025990A1 (de)
ZA (1) ZA97310B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
CA2765630C (en) 2009-06-26 2016-07-05 Taris Biomedical, Inc. Solid drug tablets for implantable drug delivery devices
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
FI20021701L (fi) * 1991-01-30 2002-09-24 Wellcome Found Veteen dispergoituvia tabletteja
EP0586523A4 (en) 1991-05-15 1995-11-29 Univ Yale Determination of prodrugs metabolizable by the liver and therapeutic use thereof
GB9303157D0 (en) * 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Also Published As

Publication number Publication date
EA199800573A1 (ru) 1999-02-25
HUP9901021A3 (en) 2000-08-28
TR199800954T2 (xx) 1998-10-21
EP0874632B1 (de) 2002-07-24
UA63897C2 (en) 2004-02-16
DZ2159A1 (fr) 2002-12-01
DE69714215D1 (de) 2002-08-29
MX9805713A (es) 1998-10-31
AR005456A1 (es) 1999-06-23
CZ287205B6 (en) 2000-10-11
PL327922A1 (en) 1999-01-04
CY2390B1 (en) 2004-09-10
US6765007B1 (en) 2004-07-20
EA001946B1 (ru) 2001-10-22
ZA97310B (en) 1997-10-23
CN1132582C (zh) 2003-12-31
KR19990077229A (ko) 1999-10-25
NO983259D0 (no) 1998-07-15
ATE220910T1 (de) 2002-08-15
NO983259L (no) 1998-07-15
UY24437A1 (es) 1997-06-06
AP9700911A0 (en) 1997-01-31
AP9801298A0 (en) 1998-09-30
DE69714215T2 (de) 2003-01-23
JP4711360B2 (ja) 2011-06-29
MY127527A (en) 2006-12-29
ES2180922T3 (es) 2003-02-16
BR9706982A (pt) 1999-07-20
JP2000503311A (ja) 2000-03-21
EG23684A (en) 2007-05-09
AU1541897A (en) 1997-08-11
UY24556A1 (es) 2001-08-27
DK0874632T3 (da) 2002-11-11
SK282132B6 (sk) 2001-11-06
PE35498A1 (es) 1998-08-07
NZ326769A (en) 2000-05-26
AP747A (en) 1999-05-03
NO315689B1 (no) 2003-10-13
JP2009091362A (ja) 2009-04-30
BG102638A (bg) 1999-07-30
GB9600847D0 (en) 1996-03-20
PL187291B1 (pl) 2004-06-30
KR100338829B1 (ko) 2002-07-18
AP1114A (en) 2002-10-18
CZ225498A3 (cs) 1998-12-16
IL124913A0 (en) 1999-01-26
PT874632E (pt) 2002-10-31
SK95698A3 (en) 1999-01-11
OA10812A (en) 2003-01-29
WO1997025990A1 (en) 1997-07-24
TW434016B (en) 2001-05-16
HUP9901021A2 (hu) 1999-08-30
CN1208350A (zh) 1999-02-17
HK1016473A1 (en) 1999-11-05
HU225472B1 (en) 2006-12-28
EP0874632A1 (de) 1998-11-04
AU713090B2 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
KR100348842B1 (ko) 염기성물질로안정화된약제학적조성물
EP3417861A1 (de) Pharmazeutische zusammensetzung mit jak-kinaseinhibitor oder pharmazeutisch unbedenklichem salz davon
SK96497A3 (en) Valaciclovir tablet, preparation method thereof and their use
SK369292A3 (en) Orally administerable drugs for the treatment of central dopamine deficiency conditions
JP2009091362A6 (ja) 高含量ファムシクロビル錠剤
JP2009091362A (ja) 高含量ファムシクロビル錠剤
RU2401109C2 (ru) Таблетированный препарат с замедленным высвобождением для вертиго
US3891755A (en) Dosage formulation for erythromycin cetyl sulfate
EP0952823A1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
JP2001233766A (ja) プラバスタチンナトリウムの錠剤
BG61242B2 (bg) Твърд фармацевтичен състав за орална употреба на база дапипразол
US6737419B2 (en) Benazepril hydrochloride tablet formulations
CA2240462C (en) High-content famciclovir tablets
HK1016473B (en) High-content famciclovir tablets
EP1889629A1 (de) Stabile Zubereitung enthaltend eine Kombination aus einer feuchtigkeitsempfindlichen aktiven Substanz und einer zweiten aktiven Substanz und Verfahren zur Herstellung der Zubereitung.
CA2659814A1 (en) Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
HK1116684A (en) Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
EP3372227A1 (de) Tablettenformulierung von adefovir dipivoxil
KR20090021222A (ko) 수분 민감성 약물 및 제2 약물의 배합을 포함하는 안정한 제제 및 이의 제조 방법
HU215191B (hu) Eljárás Levodopa és Carbidopa hatóanyag-kombinációt tartalmazó, szabályozott hatóanyag-leadású, központi dopaminhiányos állapotok kezeléséhez alkalmas orális gyógyszerkészítmény előállítására